Christine Blazynski PhD
Innovation Head Informa Pharma Intelligence
+21 year(s) experience
Christine's role is to identify areas of unmet need in business intelligence for biopharma and healthcare clients, and to foster product, process and organizational innovation within Informa Pharma Intelligence. Christine also work's with data from across the business to reveal trends or paradigm shifts that impact healthcare.
She joined Informa through the Citeline acquisition in late 2006. At that time, Christine headed editorial operations, product evolution, new product development and content strategy. She has written numerous white papers on trends in clinical development, pipeline rationalization, clinical trial terminations and business strategy using the wealth of data offered by Informa’s intelligence products.
Christine's educational background is in biochemistry and biophysics. She earned a PhD from Purdue University and BS degree from the University of Scranton. Christine was on the faculty at Washington University School of Medicine in the departments of Biochemistry & Molecular Biophysics, Ophthalmology, and Anatomy & Neurobiology. She Ieft academia to pursue a career in market research and business analysis first at Decision Resources and then with Citeline/Informa.
In Christine's role heading Innovation, her goal is to listen to clients’ and non-clients’ needs for better intelligence and predictive analyses in order to inform where Informa invests its resources.
By Christine Blazynski PhD 30 May 2017
Company pipeline depictions are snapshots that illustrate, at that point in time, where a therapeutic candidate sits in terms of development stage for a specific therapy area or disease.
By Christine Blazynski PhD 12 Dec 2014
Over the past year, Citeline has been monitoring 360 public Chinese hospitals.
Topic Clinical trials